HEPATOLOGY / BASIC RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Pancreaticobiliary maljunction (PBM) leads to higher rates of complications, including cholangitis, pancreatitis, and malignancies. The aim of the present study was to investigate the expression profile of long non-coding RNAs (lncRNAs) and their potential role as biomarkers in children with pancreaticobiliary maljunction.

Material and methods:
The differential expression of lncRNAs and messenger RNA (mRNAs) from pediatric patients with pancreaticobiliary maljunction and control subjects was analyzed using a commercial microarray and later validated with qRT-PCR. The potential biological functions of differentially expressed genes were explored based on Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment. The ability of potential lncRNA biomarkers to predict pancreaticobiliary maljunction was assessed based on the area under the receiver operating characteristic curve (AUC).

Results:
There were 2915 mRNAs and 173 lncRNAs upregulated, and 2121 mRNAs and 316 lncRNAs downregulated in PBM cases compared to controls. The enriched Gene Ontology categories associated with differentially expressed mRNAs were extracellular matrix, extracellular region, and kinetochore. The most enriched Kyoto Encyclopedia pathway was protein digestion and absorption, which was associated with cancer and PI3K-Akt signaling. Analysis of cis- and trans-target genes predicted that a single lncRNA was able to regulate several mRNAs. The qRT-PCR results for NR_110876, NR_132344, XR_946886, and XR_002956345 were consistent with the microarray results, and the difference was statistically significant for NR_132344, XR_946886, and XR_002956345 (p < 0.05). AUC was significant only for XR_946886 (0.837, p < 0.001).

Conclusions:
Our results implicate lncRNAs in common bile duct pathogenesis in PBM, and they identify XR_946886 as a potential biomarker for the disease.

 
REFERENCES (30)
1.
Le Roy B, Gagnière J, Filaire L, Fontarensky M, Hordonneau C, Buc E. Pancreaticobiliary maljunction and choledochal cysts: from embryogenesis to therapeutics aspects. Surg Radiol Anat 2016; 38: 1053-60.
 
2.
Kamisawa T, Kuruma S, Chiba K. Congenital biliary dilatation and pancreaticobiliary maljunction. Nihon Shokakibyo Gakkai Zasshi 2016; 113: 1991-7.
 
3.
Urushihara N, Hamada Y, Kamisawa T, et al. Classification of pancreaticobiliary maljunction and clinical features in children. J Hepatobiliary Pancreat Sci 2017; 24: 449-55.
 
4.
Kamisawa T, Kuruma S, Tabata T, et al. Pancreaticobiliary maljunction and biliary cancer. J Gastroenterol 2015; 50: 273-9.
 
5.
Kamisawa T, Kaneko K, Itoi T, Ando H. Pancreaticobiliary maljunction and congenital biliary dilatation. Lancet Gastroenterol Hepatol 2017; 2: 610-8.
 
6.
Eda K, Mizuochi T, Takaki Y, et al. Adenomyomatosis of the gallbladder with pancreaticobiliary maljunction in a child. J Pediatr Gastroenterol Nutr 2018; 67: e82.
 
7.
Ono S, Fumino S, Iwai N. Diagnosis and treatment of pancreaticobiliary maljunction in children. Surg Today 2011; 41: 601-5.
 
8.
Kamisawa T, Ando H, Suyama M, Shimada M, Morine Y, Shimada H; Working Committee of Clinical Practice Guidelines for Pancreaticobiliary Maljunction; Japanese Study Group on Pancreaticobiliary Maljunction. Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol 2012; 47: 731-59.
 
9.
Guo WL, Zhan Y, Fang F, et al. Factors affecting the operating time for complete cyst excision and Roux-en-Y hepaticojejunostomy in paediatric cases of congenital choledochal malformation: a retrospective case study in Southeast China. BMJ Open 2018; 8: e022162.
 
10.
Tsuchida A, Kasuya K, Endo M, et al. High risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation. Oncol Rep 2003; 10: 1183-7.
 
11.
Kobayashi S, Asano T, Yamasaki M, Kenmochi T, Nakagohri T, Ochiai T. Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction. Surgery 1999; 126: 939-44.
 
12.
Sheng Q, Lv Z, Xu W, Xiao X, Liu J, Wu Y. Reoperation after cyst excision with hepaticojejunostomy for choledochal cysts: our experience in 18 cases. Med Sci Monit 2017; 23: 1371-7.
 
13.
Sugiura T, Endo T, Ito K, et al. Recurrent cholangitis with congenital hepatic fibrosis and pancreaticobiliary maljunction after Roux-en-Y reconstruction. European J Pediatr Surg Rep 2013; 1: 43-5.
 
14.
Song W, Miao DL, Chen L. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma. Biochem Biophys Res Commun 2018; 506: 1004-12.
 
15.
Liu J, Chen L, Pan J, et al. Comprehensive analysis of key lncRNAs in HCV-positive hepatocellular carcinoma. Arch Med Sci 2020; 17: 142-51.
 
16.
Ren GJ, Fan XC, Liu TL, Wang SS, Zhao GH. Genome-wide analysis of differentially expressed profiles of mRNAs, lncRNAs and circRNAs during Cryptosporidium baileyi infection. BMC Genomics 2018; 19: 356.
 
17.
Dolcino M, Pelosi A, Fiore PF, et al. Long non-coding RNAs play a role in the pathogenesis of psoriatic arthritis by regulating microRNAs and genes involved in inflammation and metabolic syndrome. Front Immunol 2018; 9: 1533.
 
18.
Tang Y, Zhou T, Yu X, Xue Z, Shen N. The role of long non-coding RNAs in rheumatic diseases. Nat Rev Rheumatol 2017; 13: 657-69.
 
19.
Sallam T, Sandhu J, Tontonoz P. Long noncoding RNA discovery in cardiovascular disease: decoding form to function. Circ Res 2018; 122: 155-66.
 
20.
Liang Y, Zhu H, Chen J, Lin W, Li B, Guo Y. Construction of relapse-related lncRNA-mediated ceRNA networks in Hodgkin lymphoma. Arch Med Sci 2020; 16: 1411-8.
 
21.
Zhou M, Zhao H, Xu W, Bao S, Cheng L, Sun J. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer 2017; 16: 16.
 
22.
Song P, Jiang B, Liu Z, Ding J, Liu S, Guan W. A three-lncRNA expression signature associated with the prognosis of gastric cancer patients. Cancer Med 2017; 6: 1154-64.
 
23.
Guo WL, Huang SG, Wang J, Sheng M, Fang L. Imaging findings in 75 pediatric patients with pancreaticobiliary maljunction: a retrospective case study. Pediatr Surg Int 2012; 28: 983-8.
 
24.
Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458: 223-7.
 
25.
Kaneko K, Ito Y, Ono Y, et al. Gene expression profiling reveals upregulated UCA1 and BMF in gallbladder epithelia of children with pancreaticobiliary maljunction. J Pediatr Gastroenterol Nutr 2011; 52: 744-50.
 
26.
Guo WL, Geng J, Zhao JG, Fang F, Huang SG , Wang J. Gene expression profiling reveals upregulated FUT1 and MYBPC1 in children with pancreaticobiliary maljunction. Braz J Med Biol Res 2019; 52: e8522.
 
27.
Wong JK, Campbell D, Ngo ND, et al. Genetic study of congenital bile-duct dilatation identifies de novo and inherited variants in functionally related genes. BMC Med Genomics 2016; 9: 75.
 
28.
Bhawe K, Roy D. Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression. Cell Oncol (Dordr) 2018; 41: 465-84.
 
29.
Long X, Song K, Hu H, et al. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res 2019; 38: 345.
 
30.
Zhao L, Shi SL, Guo WL. LncRNA expression prole, functional analysis and potential biomarkers in children with pancreaticobiliary maljunction. Research square. Cell Biology 2021; 5: 25.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top